Nyumbani › Colitis ya Ulcerative › Alabama
Majaribio ya kliniki ya Colitis ya Ulcerative katika jimbo la Alabama
Masomo 7 ya Colitis ya Ulcerative yanatafuta washiriki katika vituo vya jimbo la Alabama.
Miji katika jimbo la Alabama
Maandishi rasmi ya utafiti (Kiingereza)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Specialists /ID# 280827, Dothan
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health, Birmingham
- East View Medical Research, Mobile
InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Digestive Health Specialists, Dothan
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937086A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Specialsits, Dothan
InaajiriHatua 4
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06095128A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University of South Alabama (USA) Physicians Group, Mobile
InaajiriHatua 3
Umri 2 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Birmingham
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 12 Mac 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Alabama Medicine, Birmingham
Inaajiri
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 8 Jan 2026 · NCT05987852Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.